ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,068,000 | +1.4% | 13,905 | -1.2% | 0.01% | -7.1% |
| Q3 2020 | $1,053,000 | -72.8% | 14,071 | -77.1% | 0.01% | -74.1% |
| Q2 2020 | $3,874,000 | +45.6% | 61,535 | -2.8% | 0.05% | +28.6% |
| Q1 2020 | $2,661,000 | -9.1% | 63,335 | 0.0% | 0.04% | +44.8% |
| Q4 2019 | $2,929,000 | +0.8% | 63,335 | -0.2% | 0.03% | -9.4% |
| Q3 2019 | $2,906,000 | -21.9% | 63,485 | 0.0% | 0.03% | -20.0% |
| Q2 2019 | $3,723,000 | +178.5% | 63,485 | +113.0% | 0.04% | +166.7% |
| Q1 2019 | $1,337,000 | +24.5% | 29,804 | +8.1% | 0.02% | +7.1% |
| Q4 2018 | $1,074,000 | -15.3% | 27,560 | 0.0% | 0.01% | +16.7% |
| Q3 2018 | $1,268,000 | +5.5% | 27,560 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $1,202,000 | +8.1% | 27,560 | -2.1% | 0.01% | +9.1% |
| Q1 2018 | $1,112,000 | +5.7% | 28,145 | -9.1% | 0.01% | +10.0% |
| Q4 2017 | $1,052,000 | +33.3% | 30,956 | 0.0% | 0.01% | +66.7% |
| Q3 2017 | $789,000 | – | 30,956 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |